| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |